Instrumento Inactivo

Acciones Amylin Pharmaceuticals LLC

Acciones

Precio de cierre Nasdaq Otros sitios de cotización
- ^USD	-

Amylin Pharmaceuticals, Inc. : Bristol-Myers Squibb and AstraZeneca Complete Expansion of Diabetes Alliance Through Bristol-Myers Squibb's Acquisition of Amylin	09/08/12
Bristol Myers Squibb Co. : Bristol-Myers executive charged with insider trading	02/08/12
BioMarin Pharmaceutical Inc. : GSK clinches deal to buy Human Genome for $3 billion	16/07/12
GlaxoSmithKline plc : Exclusive: GSK set for Human Genome takeover - sources	16/07/12
GlaxoSmithKline plc : GSK in weekend talks to buy Human Genome: sources	15/07/12

Sector

	Varia. 1 de ene.	Capi.
CSL LIMITED	-3,79 %	88,14 mil M
SAMSUNG BIOLOGICS CO.,LTD.	+1,45 %	40,51 mil M
BIOGEN INC.	-15,94 %	31,67 mil M
UCB	+52,66 %	24,62 mil M
BIOMARIN PHARMACEUTICAL INC.	-14,50 %	15,65 mil M
INCYTE CORPORATION	-14,38 %	12,07 mil M
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9,12 %	11,97 mil M
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-42,56 %	11,61 mil M
SWEDISH ORPHAN BIOVITRUM AB	+4,87 %	8810,05 M